Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI
Zhen Qin(Henan University of Technology), Junnan Tang(University of North Carolina at Chapel Hill), Zeyu Wang(Anhui University), Li Zhang(Henan University of Technology), Yanyan Xu(Ningbo First Hospital), Shuai Xu(Xihua University), Yan Lv, Jinying Zhang(First Affiliated Hospital of Zhengzhou University), LU Yong-zheng(Henan University of Technology), Fengyi Yu(Henan University of Technology), Jing Bai(Harbin Medical University), Ruixia Yuan(First Affiliated Hospital of Zhengzhou University), Hui Zhang(Chinese University of Hong Kong)
Cited by 17
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome
|Nature Communications|2017|260
Targeted repair of heart injury by stem cells fused with platelet nanovesicles
|Nature Biomedical Engineering|2018|239